NP Life Sciences Health Industry Group Inc.
NPLS
$0.0539
-$0.0962-64.09%
| Weiss Ratings | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | D+ | |||
| Rating Factors | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.45 | |||
| Price History | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -91.02% | |||
| 2-Year Total Return | -89.43% | |||
| 3-Year Total Return | -92.81% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -89.63% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.52 | |||
| 52-Week Low Price | $0.05 | |||
| 52-Week Low Price (Date) | Jul 15, 2024 | |||
| 52-Week High Price (Date) | Apr 09, 2024 | |||
| Valuation | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.32M | |||
| Enterprise Value | 2.27M | |||
| Price/Earnings (TTM) | 134.75 | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -200.00% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 14.18 | |||
| Price/Book (Q) | 134.75 | |||
| Enterprise Value/Revenue (TTM) | 13.77 | |||
| Price | $0.05 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -3,238.96 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 42.96M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 925 362 3169 | |||
| Address | 4125 Blackhawk Plaza Circle Danville, CA 94506 | |||
| Website | www.gjcc.us | |||
| Country | United States | |||
| Year Founded | 2018 | |||
| Profitability | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -0.42% | |||
| Profit Margin | 11.72% | |||
| Management Effectiveness | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.43% | |||
| Return on Equity | 108.12% | |||
| Income Statement | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 164.60K | |||
| Total Revenue (TTM) | 164.60K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 164.60K | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -700.00 | |||
| Net Income (TTM) | 19.30K | |||
| Net Income Avl. to Common (TTM) | 19.30K | |||
| Total Revenue Growth (Q YOY) | -78.26% | |||
| Earnings Growth (Q YOY) | -192.77% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | -200.00% | |||
| Balance Sheet | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 70.60K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 76.90K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 16.40K | |||
| Current Ratio (Q) | 2.018 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 76.90K | |||
| Total Current Liabilities (Q) | 38.10K | |||
| Total Debt (Q) | 22.40K | |||
| Total Liabilities (Q) | 60.50K | |||
| Total Common Equity (Q) | 16.40K | |||
| Cash Flow | NPLS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 22.40K | |||
| Net Change in Cash (TTM) | -51.30K | |||
| Levered Free Cash Flow (TTM) | -71.40K | |||
| Cash from Operations (TTM) | -73.60K | |||
